The second edition of this handbook includes the following key features: DSM-IV incorporated throughout; new chapters on Naltrexone, Tacrine, Trazodone, Nefazodone and Venlafaxine and medication-induced movement disorders; and coverage of calcium-channel inhibitors such as Nimodipine.




